EVAX FY 2019 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena

EVAXEvaxion Biotech A/S

$23M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$80,984

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-27.60

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$11M

Total Liabilities

$2M

Stockholders' Equity

$9M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$80,984	-$73,928	-9.5%
Operating Income	-$11M	-$6M	-101.9%
Net Income	-$11M	-$6M	-102.2%